No Data
No Data
Orient 2024 annual results pre-loss announcement
Aored (600666.SH): Expected net loss in 2024 is between 90 million yuan and -0.18 billion yuan.
On January 17, 2024, Glonghui announced that, according to preliminary estimates from the finance department, it is expected that the annual net income attributable to the parent company's owners will be between -180 million yuan and -90 million yuan, which represents a reduction in losses of approximately 495.2778 million yuan to 585.2778 million yuan compared to the same period last year, which was -675.2778 million yuan. It is also expected that the net income attributable to the parent company's owners after deducting non-recurring gains and losses will be between -225 million yuan and -135 million yuan. The company's main business currently includes the production and sales of Sapphires.
Is Aurora OptoelectronicsLtd (SHSE:600666) Weighed On By Its Debt Load?
Aurora OptoelectronicsLtd (SHSE:600666) Lifts 9.3% This Week, Taking Five-year Gains to 55%
On November 25, A-share investment radar | Huaren Health: shareholder ali health plans to reduce its shareholding by no more than 12 million shares.
Ali Health, a shareholder of Chinese Health, plans to reduce its shareholding by no more than 12 million shares; shareholders of Aoride, Qiongcun Kunsun, plan to reduce their shares by a total of no more than 3%; the controlling shareholder and actual controller of Chuangshi Technology received a notice from the procuratorial agency; Jinlong Machinery & Electronic stated that it reported a related embezzlement case and received a notice of case filing; Ningbo Techmation stated that the Italian EEI company does not directly produce or develop fusion reactor devices; Tasly Pharmaceutical Group has suspended the clinical trial of Anmei monoclonal antibody.
Aurora (600666.SH): Gu Qingcheng Kunshun plans to collectively reduce their shareholding by no more than 3%.
On November 22, Gelonghui reported that Aorede (600666.SH) announced that Kongshun of Qiongcheng intends to reduce its shareholding in the company by no more than 82,905,000 shares within three months after 15 trading days from the date of this announcement, accounting for no more than 3% of the company's total share capital. Among these, the reduction through centralized bidding trading will not exceed 1% of the company's current total share capital, with a maximum reduction of no more than 27,635,000 shares; the reduction through block trading will not exceed 2% of the company's current total share capital.
BanksterTrader : give me 20 min
BanksterTrader : I dont like how the owner was barred from securities market for 10 years.. and 2 months ago two individuals (stockholders)who combine for 31.8% stake in company were also frozen by court.. i would say no but ill keep digging.. it looks like wolfofwallstreet moment here lol
Jess Walker OP BanksterTrader : lol for sure♡ ty so much for the advice. We lost my partner to covid early on and times are hard. The market is my last ditch h effort to make some money quickly.
Spartakus : i wouldnt touch it
BanksterTrader Spartakus : me either
View more comments...